| Body weight gain induced by antipsychotic drugs: mechanisms and management T Baptista Acta Psychiatrica Scandinavica 100 (1), 3-16, 1999 | 524 | 1999 |
| Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives T Baptista, N Kin, S Beaulieu, EA De Baptista Pharmacopsychiatry 35 (06), 205-219, 2002 | 402 | 2002 |
| Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial T Baptista, N Rangel, V Fernández, E Carrizo, Y El Fakih, E Uzcátegui, ... Schizophrenia research 93 (1-3), 99-108, 2007 | 199 | 2007 |
| Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial T Baptista, J Martínez, A Lacruz, N Rangel, S Beaulieu, A Serrano, ... The Canadian Journal of Psychiatry 51 (3), 192-196, 2006 | 197 | 2006 |
| An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ... Pharmacopsychiatry 55 (02), 73-86, 2022 | 187 | 2022 |
| Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are Dopamine D2 receptors involved? T Baptista, L Hernández, M Parada Pharmacology Biochemistry & Behavior 27 (3), 399-405, 1987 | 159 | 1987 |
| Pharmacological management of atypical antipsychotic-induced weight gain T Baptista, Y ElFakih, E Uzcátegui, I Sandia, E Tálamo, EA de Baptista, ... CNS drugs 22, 477-495, 2008 | 157 | 2008 |
| Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics T Baptista, J Zarate, R Joober, C Colasante, S Beaulieu, X Paez, ... Current Drug Targets 5 (3), 279-299, 2004 | 154 | 2004 |
| Lithium and body weight gain T Baptista, L Teneud, Q Contreras, T Alastre, JL Burguera, M De Burguera, ... Pharmacopsychiatry 28 (02), 35-44, 1995 | 140 | 1995 |
| Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? S Sengupta, MA Parrilla-Escobar, R Klink, F Fathalli, YK Ng, E Stip, ... Schizophrenia research 102 (1-3), 329-336, 2008 | 137 | 2008 |
| Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study E Carrizo, V Fernández, L Connell, I Sandia, D Prieto, J Mogollón, ... Schizophrenia Research 113 (1), 19-26, 2009 | 129 | 2009 |
| Comparative effects of the antipsychotics sulpiride or risperidone in rats: I: Bodyweight, food intake, body composition, hormones and glucose tolerance T Baptista, EA de Baptista, NMKNY Kin, S Beaulieu, D Walker, R Joober, ... Brain Research 957 (1), 144-151, 2002 | 129 | 2002 |
| Antipsychotic drugs and obesity: is prolactin involved? T Baptista, A Lacruz, T Meza, Q Contreras, C Delgado, MA Mejìas, ... The Canadian Journal of Psychiatry 46 (9), 829-834, 2001 | 95 | 2001 |
| Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives E Carrizo, V Fernández, J Quintero, L Connell, Z Rodríguez, M Mosquera, ... Schizophrenia research 103 (1-3), 83-93, 2008 | 88 | 2008 |
| Antipsychotic drugs and reproductive hormones: relationship to body weight regulation T Baptista, D Reyes, L Hernández Pharmacology Biochemistry and Behavior 62 (3), 409-417, 1999 | 88 | 1999 |
| Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs? T Baptista, S Beaulieu The Canadian Journal of Psychiatry 47 (8), 742-749, 2002 | 85 | 2002 |
| Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study T Baptista, E Uzcátegui, N Rangel, Y El Fakih, T Galeazzi, S Beaulieu, ... Psychiatry research 159 (1-2), 250-253, 2008 | 84 | 2008 |
| Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration T Baptista, A Lacruz, F Angeles, R Silvera, S De Mendoza, MT Mendoza, ... Pharmacopsychiatry 34 (06), 223-231, 2001 | 84 | 2001 |
| Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones T Baptista, A Lacruz, S De Mendoza, JM MendozaGuillén, R Silvera, ... Pharmacopsychiatry 33 (03), 81-88, 2000 | 84 | 2000 |
| Diurnal cortisol in schizophrenia patients with childhood trauma. C Braehler, D Holowka, A Brunet, S Beaulieu, T Baptista, JB Debruille, ... Schizophrenia research 79 (2-3), 353-354, 2005 | 80 | 2005 |
Luis HernandezProfessor of Physiology, Universidad de Los Andes, Merida, Venezuela在 ula.ve 的电子邮件经过验证
